Sign in
4

Changes in Ownership

Phreesia, Inc. Filed Acc 0001127602-25-004226

SVP, Life Sciences sold 300 shares at $29.52 ($8,857)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Linetsky David SVP, Life Sciences 2025-02-07 Sale 10b5-1 −300 $29.52 $8,857 229,751 D: show line 1 in the form
Open-market sales · 300 sh · avg $29.52 · $8,857
Loading xslF345X05/form4.xml…